| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.715 | 45.174 | 60.944 | 58.012 | 59.897 | 62.719 | 96.815 | 102.941 | 124.341 | 196.399 |
| Total Income - EUR | 23.715 | 45.175 | 60.945 | 58.012 | 59.897 | 62.719 | 96.815 | 102.941 | 137.606 | 228.666 |
| Total Expenses - EUR | 15.856 | 18.269 | 48.472 | 36.573 | 35.315 | 34.228 | 48.325 | 56.328 | 84.482 | 129.459 |
| Gross Profit/Loss - EUR | 7.858 | 26.907 | 12.473 | 21.439 | 24.582 | 28.491 | 48.490 | 46.614 | 53.124 | 99.207 |
| Net Profit/Loss - EUR | 7.147 | 25.903 | 11.864 | 20.859 | 23.983 | 27.905 | 47.541 | 45.584 | 51.881 | 93.315 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Biogyn Life Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.054 | 10.997 | 41.459 | 30.272 | 19.462 | 15.214 | 11.637 | 8.557 | 199.601 | 215.902 |
| Current Assets | 378 | 25.253 | 1.749 | 2.491 | 5.408 | 37.443 | 6.460 | 16.658 | 5.201 | 28.573 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3 | 50 | 585 | 0 | 0 | 0 | 40 | 0 | 0 | 612 |
| Cash | 375 | 25.203 | 1.164 | 2.491 | 5.408 | 37.443 | 6.420 | 16.658 | 5.201 | 27.961 |
| Shareholders Funds | 9.251 | 25.948 | 11.908 | 32.548 | 24.607 | 52.046 | 17.441 | 11.313 | 677 | 32.665 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 80 |
| Debts | 2.180 | 10.302 | 31.300 | 214 | 263 | 611 | 656 | 13.902 | 28.593 | 49.523 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 175.533 | 162.287 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Biogyn Life Srl